EULAR® 2024 Insights

 

Spondyloarthropathies
20:07

EULAR® 2024 Insights

Highlights of EULAR 2024 in Spondyloarthritis and Psoriatic Arthritis

FEATURING Krystel Aouad
  • 270 views
  • July 30, 2024
  • 2
09:51

EULAR® 2024 Insights

Clinical features of patients with SpA, with or without IBD: results from the METEOR cohort

FEATURING Manouk De Hooge
  • 10 views
  • July 24, 2024
08:34

EULAR® 2024 Insights

EULAR® 2024 Insights- Reasons for Non-response to Treatments in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Classified as Difficult to Treat

FEATURING Fulya Coşan
  • 8 views
  • July 16, 2024
09:55

EULAR® 2024 Insights

EULAR® 2024 Insights: Reasons for Non-response to Treatments in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Classified as Difficult to Treat

FEATURING Fulya Coşan
  • 61 views
  • July 10, 2024
  • 1
06:35

EULAR® 2024 Insights

EULAR® 2024 Insights: Impact of Peripheral Arthritis on Disease Activity Outcomes in Patients With Axial Spondyloarthritis, Peripheral Spondyloarthritis and Psoriatic Arthritis - Data From the ASAS-PerSpA Study

FEATURING Clementina Lopez-Medina
  • 1 view
  • June 26, 2024
11:13

EULAR® 2024 Insights

EULAR® 2024 Insights: Apremilast Treatment in Early Oligoarticular Psoriatic Arthritis (PsA) Improves Clinical and Patient-Reported Outcomes for up to 48 Weeks - Data From the FOREMOST Study

FEATURING Laure Gossec
  • 14 views
  • June 26, 2024
05:42

EULAR® 2024 Insights

EULAR® 2024 Insights: Associations Between Clinical Characteristics and Screening MRI Findings: Exploratory Analysis of the Ongoing Phase 4, Multicenter, Randomized, Controlled STAR Study of Biologic-naïve Patients with PsA with MRI-confirmed Axial Involvement

FEATURING Enrique R. Soriano
  • 3 views
  • June 25, 2024
04:06

EULAR® 2024 Insights

EULAR® 2024 Insights - Factors Associated with the Evolution of Degenerative Spinal Lesions in Axial Spondyloarthritis: 10-year Follow-up of the DESIR Cohort

FEATURING Laura Pina Vegas
  • 38 views
  • June 21, 2024
  • 1
05:43

EULAR® 2024 Insights

EULAR® 2024 Insights: Chronic Kidney Disease in Patients with Psoriatic Arthritis: A Cohort Study

FEATURING Dafna Gladman
  • 65 views
  • June 21, 2024
  • 1
04:54

EULAR® 2024 Insights

EULAR® 2024 Insights: Guselkumab Provides Durable Improvements in Pain Among Patients With Psoriatic Arthritis and an Inadequate Response to TNFi: COSMOS Phase 3b Trial

FEATURING Laura Coates
  • 48 views
  • June 21, 2024
33:05

EULAR® 2024 Insights

EULAR® 2024 Insights: Spot on Treatment Failure in PsA: Where Are the Management Problems

FEATURING Vinod Chandran
  • 104 views
  • June 21, 2024
  • 1
09:15

EULAR® 2024 Insights

EULAR® 2024 Insights - Sex-Related Differences in Trial Outcomes in AxSpa Randomized Clinical Trials: A Systematic Literature Review and Meta-Analysis

FEATURING Lihi Eder
  • 52 views
  • June 18, 2024
04:46

EULAR® 2024 Insights

EULAR® 2024 Insights: Drug Survival of First-line TNF and Apremilast and Description of Second-line Therapy among PsA Patients in the CorEvitas PsA/SpA Registry

FEATURING Alexis Ogdie
  • 80 views
  • June 18, 2024
07:39

EULAR® 2024 Insights

EULAR® 2024 Insights - Enhancing the Diagnostic Accuracy and Avoiding Overdiagnosis in Axial Spondyloarthritis Through Central Evaluation of Imaging: Improve-axSpA, a Nationwide Telemedicine Project

FEATURING Denis Poddubnyy
  • 99 views
  • June 18, 2024
  • 1